Ocena przydatnosci metody TRAP do pomiaru aktywnosci telomerazy w nowotworach skory psow

• Autorzy: Zmudzka M , Micun J. , Lechowski R.

Warianty tytułu

EN

Evaluating TRAP assay for telomerase activity measurement in canine skin neoplasm's

• Języki publikacji: PL

Abstrakty

EN

The aim of the study was to evaluate the TRAP assay method of measuring telomerase activity in canine skin neoplasms. Telomerase activity was measured in 57 samples of tumor tissues from operated dogs. The samples were also subjected to histopathology investigations. Telomerase activity was measured using the Telo TAGGG Telomerase PCR ELISA diagnostic kit as well as ROCHE . photometric enzyme immunoassay for quantitative determination of telomerase activity, utilizing the telomere repeat amplification protocol (TRAP). The repetition, sensitivity and specificity of telomerase activity measurements were determined. TRAP assay performed in dogs has high repetition rate within high activity, and lower within small activity. This method is 100% sensitive and 34% specific.

Słowa kluczowe

PL

nowotwory; psy; telomeraza; aktywnosc enzymatyczna; nowotwory skory; metoda TRAP; choroby zwierzat; markery nowotworowe

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2006
• Tom: 62
• Numer: 08
• Opis fizyczny: s.905-908,tab.,bibliogr.

Twórcy

autor

Zmudzka M

• Szkola Glowna Gospodarstwa Wiejskiego, ul.Nowoursynowska 159c, 02-776 Warszawa

autor

Micun J.

autor

Lechowski R.

Bibliografia

• 1.Ahmed A., Tollefsbol T.: Telomeres and telomerase: basic science implications for aging. J. Am. Geriatr. Soc. 2001, 49, 1105-1109.
• 2.Argyle D. J., McKevitt T. P., Paoloni M., Long S., Gault E. A., Nasir L.: Targeting telomerase in canine cancer. Genes, Dogs, and Cancer: 3rd Annual Canine Cancer Conf. California 2003, s. 55-59.
• 3.Biller B., Kitchell B.: Evaluation of an assay for detecting telomerase activity in neoplastic tissues of dogs. Am. J. Vet. Res. 1998, 59, 234-237.
• 4.Blasco M. A.: Mouse models to study the role of telomeres in cancer, aging and DNA repair. Europ. J. Cancer 2000, 38, 2222-2228.
• 5.Chan S., Blackburn E.: Telomeres and telomerase. Phil. Trans. R. Soc Lond. B. 2004, 359, 109-121.
• 6.Chen J., Greider C.: Telomerase RNA structure and function: implications for dyskeratosis congenital. Trends Biochem. Sci. 2004, 29, 183-192.
• 7.Dembiñska-Kieæ A., Naskalski J.: Diagnostyka laboratoryjna z elementami biochemii klinicznej. Volumed, Wroc³aw 1998, s. 73-79.
• 8.Diepgen T. L., Mahler V.: The epidemiology of skin cancer. Bri. J. Dermatol. 2002, 146, 1-6.
• 9.Fedrige R., Gunelli R., Nanni O., Bacci F., Amadori D., Calistri D.: Telomerase activity detected by quantitive assay in bladder carcinoma and exfoliated cells in urine. Neoplasia 2001, 3, 446-450.
• 10.Hahn W. C., Meyerson M.: Telomerase activation, cellular immortalisation and cancer. Ann Med. 2001, 33, 123-129.
• 11.Harley C. B., Villeponteau B.: Telomeres and telomerase in aging and cancer. Curr. Biol. 1998, 8, 178-181.
• 12.Hiyama E., Gollahon L., Kataoka T.: Telomerase activity in human breast tumors. J. Natl Cancer 1996, 88, 1161-1172.
• 13.Hu S., Chan H.: Telomerase expression in bening and malignant skin neoplasm: comparison of three major subunits. J. Formos. Med. Assoc. 2002, 101, 593-597.
• 14.Katalinic A., Kunze U., Schäfer T.: Epidemiology of cutaneous melanoma and non-melanoma skin cancer. Br. J. Dermatol. 2003, 149, 1200-1206.
• 15.Kim N. W., Piatyszek M. A., Prowse K. R., Harley C. B., West M. D., Ho P. L., Coviello G. M., Wright W. E., Weinrich S. L., Shay J. W.: Specific assocition of human telomerase activity with immortal cells and cancer. Science 1994, 266, 2011-2015.
• 16.Kitchell B., Biller B. J., Cadile C. D., Balkin R. G.: Telomerase and canine cancer; genes, dogs, and cancer: Emerging concepts in molecular diagnosis and therapy. Conf. California 2002, s. 267-280.
• 17.Malicka E., Piusiñski W., Sendecka H., Bielecki W., Osiñska B., Lenartowicz-Kubrat Z.: Nowotwory psów stwierdzane w badaniach anatomopatologicznych w latach 1985-1993. Medycyna Wet. 1996, 52, 103-106.
• 18.Miracco C.: Detection of telomerase activity and correlation with mitotic and apoptic indices, Ki67 and expression of cyclin D1 and A in cutaneous melanoma. Int. J. Cancer 2000, 88, 411-416.
• 19.Murakami Y., Teteyama S., Rungsipipat A., Uchida K., Yamaguchi R.: Immunohistochemical analysis of cyclin A, cyclin D1 and P53 in mammary tumors, sqamous cell carcinomas and basal cell tumors of dogs and cats. J. Vet. Med. Sci. 2000, 62, 743-750.
• 20.Nasir L., Devlin T., Mckevitt T., Rutteman G., Argyle D.: Telomer lenghs and telomerase activity in dig tissues: a potential model to study human telomer and telomerase biology. Neoplasia 2001, 3, 351-359.
• 21.Novak K. D.: Telomeres and telomerases in cancer. AACR Special Conf. San Francisco, 7-11.12.2002, s. 32-39.
• 22.Ogoshi M., Le T., Shay J. W., Taylor R. S.: In situ hybridization analysis of the expression of human telomease RNA in normal and pathologic conditions of the skin. J. Inv. Derm. 1998, 110, 818-823.
• 23.Olech W., Wieczorek M.: Zastosowanie metod statystyki w doświadczalnictwie zootechnicznym. Wyd. SGGW, Warszawa 2002, s. 47.
• 24.Parris C., Jezzard S.: Telomerase activity in melanoma and non-melanoma skin cancer. Br. J. Cancer 1999, 79, 47-53.
• 25.Ramirez R.: Telomerase activity concentrates in the mitotically active segments of human hair follicles. J. Invest. Dermatol. 1997, 108, 113-117.
• 26.Sendecka H., Malicka E., Piusiñski W., Bielecki W., Krawiec M., Osiñska B., Sobczak M.: Nowotwory u zwierząt w badaniach diagnostycznych Zakładu Anatomii Patologicznej Wydziału Weterynaryjnego w Warszawie w latach 1987-1996. I Konf. Nauk.: Onkologia weterynaryjna. Postêpy w diagnostyce i terapii. Olsztyn 4-5.09.1997, s. 67-70.
• 27.Shay J. W., Zou Y., Hiyama E., Wright W. E.: Telomerase and cancer. Hum. Mol. Genet. 2001, 10, 677-685.
• 28.Spangler E., Rogers K., Thomas J., Pusteyovsky D., Boyd S., Shippen D.: Telomerase enzyme activity as a diagnostic tool to distinguish effusions of malignant and bening origin. J. Vet. Med. 2000, 14, 146-150.
• 29.Sulaimon S., Kitchell B., Ehrhart E.: Immunohistochemical detection of melanoma-specific antigens in spontaneous canine melanoma. J. Comp. Pathol. 2002, 127, 162-168.
• 30.Ueda M., Bito T.: Telomerase activity in human skin and skin tumor. J. Dermat. Sci. 2000, 13, 345-349.
• 31.Villa R.: Telomerase activity by transcription and alternative splicing of telomerase reverse transcriptase in human melanoma. J. Invest. Dermat. 2001, 116, 867-873.